FDA MDEpiNet Panel: Device Surveillance Balancing Act

“We want a system that knows enough not to trigger panic when it’s simply the steam of boiling water,…[but] perhaps there should be some alerting when the entire oven is on fire,” said Boston cardiologist Frederic Resnic at the annual gathering of the public-private Medical Device Epidemiology Network.

Improving safety surveillance of devices in the U.S. will require a balancing act: On the one hand, establishing a robust framework for post-market data collection, but on the other hand, ensuring that the framework does not overburden users and trigger public alarm without real cause.

“We want a system that knows enough not to trigger panic when it’s simply the steam of boiling water, and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

Medical Device Recalls Down In Q1 For Lowest Quarterly Count In 3 Years. But Will It Last?

 

Despite a surge in product recalls across five key industries in the first quarter of the year, medical device recalls were down, according to Sedgwick’s latest recall index. But the firm noted they’ve since ticked up.

23andMe Genetic Tests Among 12 New FDA Classifications

 
• By 

A late-August batch of device classifications from the US FDA includes genetic tests from 23andMe, hand-held spinal surgery tools, and several IVDs.

Why EU Innovators Face Growing Barriers With EU Combination Product Regulation

 

Combination products are no longer fringe – they are the “new normal,” consultant Stephen O’Rourke told Medtech Insight. The EU has the expertise to handle the regulatory complexity, but only if connects the dots between silos. That’s the challenge, he said, and the opportunity.

UK MHRA Ready To Evolve Approach To In-House Manufactured Medtech

 
• By 

The UK device regulator wants to align health institution device exemptions with its evolving policy of agile regulation of medtech in the British market. It asks stakeholders to complete a survey by Sept. 15.

More from Policy & Regulation